Abstract
Current platforms for cancer surgery are inherently imprecise and this is manifest in high rates of incomplete excision and reoperative intervention. A prominent example is breast conserving surgery where intra-operative determination of margin involvement is challenging leading to high national average rates of positive resection margins needing revisional procedures. To meet these demands of improved precision it is valuable to image the resected tissue in real time in such a way that enables tissue characterization. A plethora of imaging methods have been proposed, with X-ray micro-CT appearing as one of the most promising due to its ability to scan the entire resection in 3D, as opposed to 2D imaging methods and/or approaches that only allow sampling the tissue at specific locations with limited field-of-view. A key, well-known limitation is the limited soft tissue sensitivity of X-rays, which has recently been overcome through the advent of X-ray phase contrast imaging (XPCI). The introduction of XPCI methods working with conventional sources (as opposed to specialized facilities such as synchrotrons) has spawn a series of exciting studies aiming at translating XPCI into clinical applications, which have recently extended into the realm of intra-operative imaging for breast conserving surgery and other areas. This article briefly introduces the XPCI technology, then reviews its existing applications in intra-operative imaging.
1 Intra-operative imaging
Most surgically resected specimens are examined via conventional histopathology, the results of which become available in a few weeks after surgery. While this is acceptable in some areas, there are others where immediate, real-time knowledge of e.g., margin status and tumor stage would be highly beneficial (; ), and some where this knowledge is essential. A typical example of the latter is breast conserving surgery, as positive margin involvement detected days later at histopathology assessment commonly leads to a second, and sometimes even a third re-operation. Re-operations are a significant burden first and foremost to patients, to whom they cause discomfort, stress and worse cosmetic outcomes and breast-related quality of life, plus they are associated with a significant increase in healthcare costs (). As can be expected, the incidence of re-operations varies globally and among centers, with median and peak approaching 20% and 40% respectively ().
The ability to determine margin involvement in real time during the operation itself and provide immediate feedback to the surgical team would allow the latter to resect more tissue where necessary, thereby reducing the incidence of re-operations. Current practice in the UK involves imaging the resected tissue (“wide local excision”, WLE) with a specimen radiography system () which, however, only provides a partial solution due to a) the limited soft-tissue sensitivity of conventional X-rays () and b) its 2D nature, which means margins orthogonal to the imaging axis are occluded in the projection, making their assessment extremely difficult ().
Several imaging techniques have been proposed to overcome the limitations of specimen radiography. Discussing them in detail lies beyond the scope of the present article, however a partial list would include Raman spectroscopy (), optical coherence tomography () and methods based on radiofrequency () and optical sectioning microscopy (; ). All these techniques probe specimens only at specific locations, which can be a barrier to effective and rapid implementation. The limited field of view can also lead to complex image mosaicking, and tissue interface artifacts can affect optical methods (). Optical Coherence Tomography shows promise and has been used to illuminate the entire specimen surface, however the effective imaging depth is limited to approximately 2 mm (), and reported sensitivity values vary significantly, recently reported at 69% () vs. more optimistic estimates previously reported by . Methods based on radiofrequency and bioimpedance spectroscopy have shown low specificity (), with a recent UK trial failing to show any difference in reoperative intervention resulting from their use . Recent approaches also include detection of Cherenkov radiation directly from the tumor bed (), which requires administering radionuclides to the patients, and mass spectrometry coupled to a surgical scalpel (), which is still under assessment. The latter method shows promise and is one of the key achievements in the area, but cannot detect close margins and requires collecting molecular signatures from all lesions.
Finally, it is important to mention cytopathological approaches such as frozen section and imprint cytology, sometimes referred to as intraoperative consultation (); these are highly accurate techniques, but they are also time consuming, costly and labour intensive; for this reason, no institutions in the UK currently uses them ().
In this complex and evolving scenario, X-ray micro-CT was shown to possess several ideal characteristics, such as tissue penetration, spatial resolution, and especially full volumetric visualization of the entire specimen () which, where contrast is appropriate, allows following strands protruding from the main tumor mass to ascertain whether they reach the specimens’ margins. Indeed, some studies have demonstrated accuracy comparable and possibly superior to other proposed methods (). However, the main limitation of conventional micro-CT is the already mentioned limited soft tissue sensitivity, which possibly explains why sensitivity values of ∼50% or just above are often reported (; ). X-ray phase contrast imaging (XPCI) was repeatedly demonstrated to overcome the soft-tissue sensitivity limitations of conventional X-rays while maintaining resolution, penetration power and full 3D visualization; in a proper implementation, it can therefore provide a valuable solution in intra-operative breast imaging and other surgical applications.
For completeness, we mention that x-ray diffraction has also been proposed for intra-operative use, due to its potential to increase specificity (). It has to be noted, however, that experimental implementations so far have been characterized by excessively long acquisition times (e.g., 5–7 h for a two-dimensional image in ). Although improvements in source technology and more efficient geometries such as the fan beam approach proposed by Stryker et al. could ameliorate this, it is unlikely the technique could reach the 10–15′ scan times required in intra-operative imaging in breast conserving surgery, especially in a (preferrable) three-dimensional imaging implementation.
2 X-ray phase contrast imaging (XPCI)
Following pioneering experiments in the mid-60s () XPCI found large diffusion in the mid-90s, mostly thanks to the advent of third generation synchrotron sources; its huge potential in medical imaging was rapidly recognized (). One of the earliest medical applications to be targeted was mammography, as various XPCI methods immediately showed image quality largely outperforming clinical practice (; ); indeed, mammography was also the area where the first clinical study on human patients was performed, still at a synchrotron (; ). This study was based on the simplest XPCI approach, propagation-based (PB) XPCI, which does not require the use of any optical elements (Figure 1), but requires a “spatially coherent” (simplifying, small and distant) focal spot, as is readily available at synchrotrons.
FIGURE 1
At that stage, the necessity to rely on large, expensive and highly specialized facilities such as synchrotrons (only approximately 50 of which exist in the world) severely limited the diffusion of XPCI, and de facto prevented medical uses apart from specific studies like the above. However, in the mid-00s, techniques emerged that enabled XPCI to be implemented with conventional sources (Figure 2), such as Talbot-Lau interferometry (TLI, ) and Edge Illumination (EI, ).
FIGURE 2
Later, the advent of novel source technology allowing higher fluxes from small focal spots (and therefore featuring higher spatial coherence than conventional X-ray tubes) such as those based on Liquid Metal Jet (LMJ) anodes () allowed pre-existing methods such as PB XPCI to be implemented in more compact setups (). Concurrently, they also allowed additional techniques born at synchrotrons that require spatial coherence such as speckle-based imaging (), characterized by a “random” beam modulator, to be implemented on a laboratory scale (). More recent research making use of absorbing (as opposed to phase-shifting) random modulators, effectively a “hybrid” between EI (it its “single mask” embodiment, see e.g., ) and speckle-based imaging, may allow relaxing the spatial coherence requirements, ultimately leading to implementations with non-micro-focal X-ray sources ().
The development of these novel approaches allowed imaging tissue specimens outside synchrotrons and in standard labs, prospectively opening the way to digital histology and, more recently, intra-operative imaging.
3 Applications of XPCI to intra-operative imaging
Interest in the use of XPCI for tissue specimen imaging (for e.g., “digital histology”) arose already with synchrotrons which, due to their “ideal X-ray source” nature, allow superb image quality, including of breast tissue: exquisite examples can be seen in e.g., and . Successful attempts were made to obtain at least comparable image quality with TLI (; ); example images are reported in Figure 3.
FIGURE 3
The main issue with the results reported in Figure 3 is acquisition times, which range from ∼7 (
A breakthrough in the ability to achieve acquisition speeds compatible with intra-operative imaging in XPCI came from
FIGURE 4

XPCI micro-CT images of breast tissue with EI and laboratory sources. (a) Shows a phase CT slice where arrows 1 and 2 show an involved margin and tumor-induced inflammation, respectively; these are confirmed by H&E histopathology (b), the appearance of which is remarkably similar to the EI phase micro-CT image. Tumor inhomogeneity is also detected (red arrow), similarly to results shown in Figure 3a but with much faster scans. For comparison, (c) shows a conventional specimen radiography image of the same sample, highlighting the extreme difficulty in extracting the same information. (d) Uses a different sample to demonstrate the method’s ability to visualize DCIS (bottom half of the image), again with matching H&E results (top half). Adapted under the terms of the Creative Commons Attribute License, CC-BY 4.0 license from
Unlike TLI and speckle methods that are characterized by uneven image backgrounds, the relatively large mask periods in EI allow the acquisition of a perfectly flat field in the absence of a sample (see Figure 2b: despite the relative misalignment between the two masks, all detector pixels are illuminated in the same way). This allows a straightforward translation of Paganin’s method, enabling effective phase retrieval (for homogeneous samples) from single projections, which in turn allows flyscan acquisitions with continuous sample rotation. Based on this principle, Diemoz et al. demonstrated unprecedented phase-retrieved micro-CT scan times of 3 min for biological samples using conventional rotating anode X-ray sources. This innovation prompted a study on breast tissue specimens aimed at intra-operative imaging (
A first part of the Massimi et al. study scanned >100 in vitro formalin-fixed breast tissue specimens, approximately half of which contained cancer. As well as with EI XPCI micro-CT, all specimens were also imaged with conventional specimen radiography and underwent histopathology evaluation. The study’s radiologist blindly scored both XPCI and conventional radiography images for cancer presence at margins, and histopathology was used as the ground truth against which both imaging methods were benchmarked. This showed comparable specificity (83%, 95% CI 70%–92% vs. 86%, 95% CI 73–93 for XPCI and specimen radiography, respectively), but a remarkable 260% improvement in sensitivity for the former (83%, 95% CI 60%–92% vs. 32%, 95% CI 20–49). Considering that several studies indicated that sensitivity was the last hurdle micro-CT needed to overcome to become the method of choice in intra-operative imaging (see §1), this is an extremely promising result.
For this study, the radiologist was trained ahead of undertaking the blind scoring of all XPCI images: they were given short presentations by the physicists group supported by the pathologist, during which they were able to see XPCI CT slices side-by-side with matching histopathology images. Following training, they looked at all XPCI images scoring them for cancer presence (yes/no) and cancer presence at margins (yes/no). They did the same with the conventional specimen radiography images, for which of course they needed no training. There was discussion as to whether it would be possible to train the surgical team on image interpretation so that a radiologist would not be needed, with or without the support of appropriately trained AI algorithms. These remain interesting and active areas of current and future research.
The second part of the Massimi et al. study demonstrated that the method could be seamlessly integrated into the clinical workflow, i.e., that it could scan entire, fresh WLEs in times compatible with those required by clinical workflows. An enhanced version of the scanner with a field-of-view of 9 × 9 cm2 (which 1 year of observations at the Barts hospital in London, UK indicated was sufficient to cover >90% of the cases) was deployed in a reasonable vicinity of the operating theatre. Through discussions with the surgical team, it was agreed that a maximum time of 15 min could be made available; 15 min scans were then performed, but post-scan analysis in which half the CT projections were discarded revealed that 7.5 min scans would have resulted in comparable image quality (Figure 5). It has to be specified though that these times refer only to the specimen scan and do not include the CT reconstruction time. Since the latter is a parallelizable process that can be implemented on GPUs, it was assumed the added time related to reconstruction could be considered negligible compared to the scan time in a prospective clinical system.
FIGURE 5

XPCI micro-CT images of full-size (container diameter 5 cm) fresh WLEs obtained with a dedicated intra-operative EI XPCI scanner and 15 (a) and 7.5 min (b) scan time. Adapted under the terms of the Creative Commons Attribute License, CC-BY 4.0 license from
Another option to speed up acquisitions is to apply Paganin et al.’s retrieval algorithm to PB XPCI, for which it was originally intended. However, unlike EI, PB XPCI requires a spatially coherent source which, from a lab deployment perspective, means a micro-focal source. The issue with micro-focal sources is their low power, which translates into low X-ray flux and therefore longer acquisitions. As an example, a widely used micro-focal source by Hamamatsu (model L12161-07) has 10 W of power in “small focus” mode, which is 120 times lower than that of the Rigaku Micro-Max 007 source used in the Massimi et al. study. Power directly translates into X-ray flux and therefore scan time.
A great opportunity in this space was created by the development of a new source technology (the LMJ) that can provide higher power from small focal spots. Indeed, to the best of our knowledge, the
For completeness, we mention two follow-up studies with EI XPCI. In the first one (
FIGURE 6

High resolution micro-CT images of breast tissue with EI and laboratory sources. (a) Shows how the “high resolution” acquisition mode allows the detection of ∼30 micron thick tumor strands (see profile in the inset), invisible in the faster, lower-resolution mode (b). Yellow arrows in (c) show the tissue’s response to chemotherapy, confirmed by the matching H&E image in (d). The red arrow indicates a residual infiltrating ductal carcinoma. Adapted with permission from IEEE Transactions on Medical Imaging (License Number 5987140428005) from
Finally,
4 Conclusions and perspectives
Various implementations of XPCI micro-CT with conventional sources have shown huge potential in digital histology, with EI and PB XPCI with LMJ sources showing promise also in intra-operative imaging, offering potentially the major achievements in the reviewed field–at least as far as x-ray based techniques are concerned.
In particular,
PB XPCI with LMJ sources provides excellent image quality with higher resolution; a remaining gap is the need to speed up acquisitions to become compatible with intra-operative practice. This could be achieved by using higher power LMJ sources that do not compromise image contrast via excessively high average X-ray energy, better detector technology, or both.
If sufficient miniaturization is achieved, laser-based sources (
Options to significantly increase resolution in EI XPCI micro-CT were demonstrated by
Finally, cost would also be an essential element of any health economics assessment looking at the adoption of the above x-ray solutions in clinical practice. EI requires masks that currently have a cost of approximately $10–20k; it should be noted, however, that most of these are “set-up” costs related to the fact that masks are being built as “one offs” to specific, custom designs; if mass-produced to a fixed design, it is reasonable to expect that their cost would reduce significantly. Therefore, they would add relatively little to the overall cost of a micro-CT machine: if the cost of the latter is considered acceptable for intra-operative use, then it is reasonable to assume that an EI version would be too. The current cost of a LMJ source is considerably higher than that of a standard x-ray source (including rotating anode); however, this too could reduce as the technology progresses.
Statements
Author contributions
AO: Conceptualization, Funding acquisition, Project administration, Supervision, Writing – original draft, Writing – review and editing. DL: Conceptualization, Supervision, Validation, Writing – review and editing.
Funding
The author(s) declare that financial support was received for the research and/or publication of this article. AO is supported by the Royal Academy of Engineering under their “Chairs in Emerging Technologies” scheme (grant CiET1819/2/78). DRL acknowledges the infrastructure support of the NIHR Imperial BRC.
Conflict of interest
AO is a named inventor on patents owned by UCL that protect the edge illumination technology, discussed among other in the paper.
The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Generative AI statement
The author(s) declare that no Generative AI was used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
ArfelliF.AssanteM.BonviciniV.BravinA.CantatoreG.CastelliE.et al (1998). Low-dose phase contrast x-ray medical imaging. Phys. Med. Biol.43, 2845–2852. 10.1088/0031-9155/43/10/013
2
AstolfoA.EndrizziM.VittoriaF. A.DiemozP. C.PriceB.HaigI.et al (2017). Large field of view, fast and low dose multimodal phase-contrast imaging at high x-ray energy. Sci. Rep.7, 2187. 10.1038/s41598-017-02412-w
3
BaranP.MayoS.McCormackM.PacileS.TrombaG.DullinC.et al (2018). High-resolution x-ray phase contrast 3-D imaging of breast tissue specimens as a possible adjunct to histopathology. IEEE Trans. Med. Imaging37, 2642–2650. 10.1109/TMI.2018.2845905
4
BonseU.HartM. (1965). An X-ray interferometer. Appl. Phys. Lett.6, 155–156. 10.1063/1.1754212
5
BundredN. J.DixonM.AchuthanR.BarrettE.BensonJ.CourtneyC. A.et al (2022). Does the use of an intraoperative device to assess margins reduce need for re-excison after breast conserving surgery: multicentre randomised controlled trial. Eur. J. Surg. Oncol.48, e221. 10.1016/j.ejso.2022.03.143
6
CastelliE.TonuttiM.ArfelliF.LongoR.QuaiaE.RigonL.et al (2011). Mammography with synchrotron radiation: first clinical experience with phase-detection technique. Radiology259, 684–694. 10.1148/radiol.11100745
7
ChangT. P.LeffD. R.ShoushaS.HadjiminasD. J.RamakrishnanR.HughesM. R.et al (2015). Imaging breast cancer morphology using probe-based confocal laser endomicroscopy: towards a real-time intraoperative imaging tool for cavity scanning. Breast Cancer Res. Treat.153, 299–310. 10.1007/s10549-015-3543-8
8
De ManB.NuytsJ.DupontP.MarchalG.SuetensP. (1999). Metal streak artifacts in X-ray computed tomography: a simulation study. IEEE Trans. Nucl. Sci.46, 691–696. 10.1109/23.775600
9
DiCorpoD.TiwariA.TangR.GriffinM.AftrethO.BautistaP.et al (2020). The role of Micro-CT in imaging breast cancer specimens. Breast Cancer Res. Treat.180, 343–357. 10.1007/s10549-020-05547-z
10
DiemozP.HagenC.EndrizziM.MinutiM.BellazziniR.UrbaniL.et al (2017). Single-shot x-ray phase-contrast computed tomography with nonmicrofocal laboratory sources. Phys. Rev. Appl.7, 044029. 10.1103/PhysRevApplied.7.044029
11
DixonJ. M.RenshawL.YoungO.KulkarniD.SaleemT.SarfatyM.et al (2016). Intra-operative assessment of excised breast tumour margins using ClearEdge imaging device. Eur. J. Surg. Oncol. (EJSO)42, 1834–1840. 10.1016/j.ejso.2016.07.141
12
DohertyA.FourmauxS.AstolfoA.ZiescheR.WoodJ.FinlayO.et al (2023). Femtosecond multimodal imaging with a laser-driven X-ray source. Commun. Phys.6, 288. 10.1038/s42005-023-01412-9
13
DonatoS.Arana PenaL. M.ArfelliF.BrombalL.ColmoL.LongoR.et al (2024). Integrating X-ray phase-contrast imaging and histology for comparative evaluation of breast tissue malignancies in virtual histology analysis. Sci. Rep.14, 5831. 10.1038/s41598-024-56341-6
14
GambariM.CladyR.StolidiA.UtezaO.SentisM.FerréA. (2020). Exploring phase contrast imaging with a laser-based Kα x-ray source up to relativistic laser intensity. Sci. Rep.10, 6766. 10.1038/s41598-020-63614-3
15
GrantY.Al-KhudairiR.St JohnE.BarschkettM.CunninghamD.Al-MuftiR.et al (2019). Patient-level costs in margin re-excision for breast-conserving surgery. J. Br. Surg.106, 384–394. 10.1002/bjs.11050
16
GrootendorstM. R.CariatiM.PinderS. E.KothariA.DouekM.KovacsT.et al (2017). Intraoperative assessment of tumour resection margins in breast-conserving surgery using 18F-FDG Cerenkov luminescence imaging: a first-in-human feasibility study. J. Nucl. Med.58, 891–898. 10.2967/jnumed.116.181032
17
HagenC. K.VittoriaF. A.MorgóO. R. i.EndrizziM.OlivoA. (2020). Cycloidal computed tomography. Phys. Rev. Appl.14, 014069. 10.1103/PhysRevApplied.14.014069
18
HellerhoffK.BirnbacherL.Sztrokay-GaulA.GrandlS.AuweterS.WillnerM.et al (2019). Assessment of intraductal carcinoma in situ (DCIS) using grating-based X-ray phase contrast CT at conventional X-Ray sources: an experimental ex-vivo study. Plos One14, e0210291. 10.1371/journal.pone.0210291
19
KennedyK. M.ZilkensR.AllenW. M.FooK. Y.FangQ.ChinL.et al (2020). Diagnostic accuracy of quantitative micro-elastography for margin assessment in breast conserving surgery. Cancer Res.80, 1773–1783. 10.1158/0008-5472.CAN-19-1240
20
KongK.ZaabarF.RakhaE.EllisI.KoloydenkoA.NotingherI. (2014). Towards intra-operative diagnosis of tumours during breast conserving surgery by selective-sampling Raman micro-spectroscopy. Phys. Med. Biol.59, 6141–6152. 10.1088/0031-9155/59/20/6141
21
KumschierT.ThalhammerJ.SchmidC.HaeuseleJ.KoehlerT.PfeifferF.et al (2024). Streak artefact removal in x-ray dark-field computed tomography using a convolutional neural network. Med. Phys.51, 7404–7414. 10.1002/mp.17305
22
LarssonD. H.TakmanP. A. C.LundströmU.BurvallA.HertzH. M. (2011). A 24 keV liquid-metal-jet x-ray source for biomedical applications. Rev. Sci. Instrum.82, 123701. 10.1063/1.3664870
23
LewisR. A. (2004). Medical phase contrast x-ray imaging: current status and future prospects. Phys. Med. Biol.49, 3573–3583. 10.1088/0031-9155/49/16/005
24
MagninC.QuenotL.BohicS.Mihai CendaD.Fernández MartínezM.LantzB.et al (2023). Dark-field and directional dark-field on low-coherence x ray sources with random mask modulations: validation with SAXS anisotropy measurements. Opt. Lett.48, 5839–5842. 10.1364/OL.501716
25
MaloneyB. W.McClatchyD. M.PogueB. W.PaulsenK. D.WellsW. A.BarthR. J. (2018). Review of methods for intraoperative margin detection for breast conserving surgery. J. Biomed. Opt.23, 1–19. 10.1117/1.JBO.23.10.100901
26
MassimiL.SuarisT.HagenC. K.EndrizziM.MunroP. R. T.HavariyounG.et al (2021). Detection of involved margins in breast specimens with x-ray phase-contrast computed tomography. Sci. Rep.11, 3663. 10.1038/s41598-021-83330-w
27
MassimiL.SuarisT.HagenC. K.EndrizziM.MunroP. R. T.HavariyounG.et al (2022). Volumetric high-resolution X-ray phase contrast virtual histology of breast specimens with a compact laboratory system. IEEE Trans. Med. Imaging41, 1188–1195. 10.1109/TMI.2021.3137964
28
McClatchyD. M.ZuurbierR. A.WellsW. A.PaulsenK. D.PogueB. W. (2018). Micro-computed tomography enables rapid surgical margin assessment during breast conserving surgery (BCS): correlation of whole BCS micro-CT readings to final histopathology. Breast Cancer Res. Treat.172, 587–595. 10.1007/s10549-018-4951-3
29
MillardT. P.EndrizziM.IgnatyevK.HagenC. K.MunroP. R. T.SpellerR. D.et al (2013). Method for automatization of the alignment of a laboratory based x-ray phase contrast edge illumination system. Rev. Sci. Instrum.84, 083702. 10.1063/1.4816827
30
MorganK. S.PaganinD. M.SiuK. K. W. (2012). X-ray phase imaging with a paper analyzer. Appl. Phys. Lett.100, 124102. 10.1063/1.3694918
31
MossR. M.AminA. S.CrewsC.PurdieC. A.JordanL. B.IacovielloF.et al (2017). Correlation of X-ray diffraction signatures of breast tissue and their histopathological classification. Sci. Rep.7, 12998. 10.1038/s41598-017-13399-9
32
NguyenF. T.ZyskA. M.ChaneyE. J.KotynekJ. G.OliphantU. J.BellafioreF. J.et al (2009). Intraoperative evaluation of breast tumor margins with optical coherence tomography. Cancer Res.69, 8790–8796. 10.1158/0008-5472.CAN-08-4340
33
OlivoA.CastelliE. (2014). X-ray phase contrast imaging: from synchrotrons to conventional sources. Riv. Nuovo Cimento37, 467–508. 10.1393/ncr/i2014-10104-8
34
OlivoA.SpellerR. (2007). A coded-aperture technique allowing x-ray phase contrast imaging with conventional sources. Appl. Phys. Lett.91, 074106. 10.1063/1.2772193
35
PaganinD.MayoS. C.GureyevT. E.MillerP. R.WilkinsS. W. (2002). Simultaneous phase and amplitude extraction from a single defocused image of a homogeneous object. J. Microsc.206, 33–40. 10.1046/j.1365-2818.2002.01010.x
36
PartridgeT.WolfsonP.JiangJ.MassimiL.AstolfoA.DjurabekovaN.et al (2024). T-staging oesophageal tumours with x-rays. Optica4, 569–576. 10.1364/OPTICA.501948
37
PfeifferF.WeitkampT.BunkO.DavidC. (2006). Phase retrieval and differential phase-contrast imaging with low-brilliance X-ray sources. Nat. Phys.2, 258–261. 10.1038/nphys265
38
PisanoE. D.JohnstonR. E.ChapmanD.GeradtsJ.IacoccaM. V.LivasyC. A.et al (2000). Human breast cancer specimens: diffraction-enhanced imaging with histologic correlation—improved conspicuity of lesion detail compared with digital radiography. Radiology214, 895–901. 10.1148/radiology.214.3.r00mr26895
39
PolikarpovM.Vila-ComamalaJ.WangZ.PereiraA.van GoghS.GasserC.et al (2023). Towards virtual histology with x-ray grating interferometry. Sci. Rep.13, 9049. 10.1038/s41598-023-35854-6
40
QiuS.-Q.DorriusM. D.de JonghS. J.JansenL.de VriesJ.SchröderC. P.et al (2018). Micro-computed tomography (micro-CT) for intra-operative surgical margin assessment of breast cancer: a feasibility study in breast conserving surgery. Eur. J. Surg. Oncol.44, 1708–1713. 10.1016/j.ejso.2018.06.022
41
RitmanE. L. (2011). Current status of developments and applications of micro-CT. Annu. Rev. Biomed. Eng.13, 531–552. 10.1146/annurev-bioeng-071910-124717
42
Roche i MorgoO.MassimiL.SuarisT.EndrizziM.MunroP. R. T.SavvidisS.et al (2021). Exploring the potential of cycloidal computed tomography for advancing intraoperative specimen imaging. Dev. X-Ray Tomogr. XIII11840, 42. 10.1117/12.2594547
43
SabelM. S.JornsJ. M.WuA.MyersJ.NewmanL. A.BreslinT. M. (2012). Development of an intraoperative pathology consultation service at a free-standing ambulatory surgical center: clinical and economic impact for patients undergoing breast cancer surgery. Am. J. Surg.204, 66–77. 10.1016/j.amjsurg.2011.07.016
44
SchnabelF.BoolbolS. K.GittlemanM.KarniT.TafraL.FeldmanS.et al (2014). A randomized prospective study of lumpectomy margin assessment with use of MarginProbe in patients with nonpalpable breast malignancies. Ann. Surg. Oncol.21, 1589–1595. 10.1245/s10434-014-3602-0
45
St JohnE. R.Al-KhudairiR.AshrafianH.AthanasiouT.TakatsZ.HadjiminasD. J.et al (2017a). Diagnostic accuracy of intra-operative techniques for margin assessment in breast cancer surgery: a meta-analysis. Ann. Surg.265, 300–310. 10.1097/SLA.0000000000001897
46
St JohnE. R.BalogJ.McKenzieJ. S.RossiM.CovingtonA.MuirheadL.et al (2017b). Rapid evaporative ionisation mass spectrometry of electrosurgical vapours for the identification of breast pathology: towards an intelligent knife for breast cancer surgery. Breast. Cancer Res.19, 59. 10.1186/s13058-017-0845-2
47
StreeterS. S.HuntB.PaulsenK. D.PogueB. W. (2022). Emerging and future use of intra-surgical volumetric X-ray imaging and adjuvant tools for decision support in breast-conserving surgery. Curr. Opin. Biomed. Eng.22, 100382. 10.1016/j.cobme.2022.100382
48
StrykerS.KapadiaA. J.GreenbergJ. A. (2021). Simulation based evaluation of a fan beam coded aperture x-ray diffraction imaging system for biospecimen analysis. Phys. Med. Biol.66, 065022. 10.1088/1361-6560/abe779
49
TakedaY.YashiroW.SuzukiY.AokiS.HattoriT.MomoseA. (2007). X-ray phase imaging with single phase grating. Jpn. J. Appl. Phys.46, L89–L91. 10.1143/JJAP.46.L89
50
TangS. S.-K.KaptanisS.HaddowJ. B.MondaniG.ElsbergerB.TasoulisM. K.et al (2017). Current margin practice and effect on re-excision rates following the publication of the SSO-ASTRO consensus and ABS consensus guidelines: a national prospective study of 2858 women undergoing breast-conserving therapy in the UK and Ireland. Eur. J. Cancer84, 315–324. 10.1016/j.ejca.2017.07.032
51
TaoY. K.ShenD.SheikineY.AhsenO. O.WangH. H.SchmolzeD. B.et al (2014). Assessment of breast pathologies using nonlinear microscopy. Proc. Natl. Acad. Sci. U. S. A.111, 15304–15309. 10.1073/pnas.1416955111
52
TwengströmW.MoroC. F.RomellJ.LarssonJ. C.SparrelidE.BjörnstedtM.et al (2022). Can laboratory x-ray virtual histology provide intraoperative 3D tumor resection margin assessment?J. Med. Imaging9, 031503. 10.1117/1.JMI.9.3.031503
53
VittoriaF. A.EndrizziM.KallonG. K.HagenC. K.IacovielloF.De CoppiP.et al (2017). Multimodal phase-based x-ray microtomography with nonmicrofocal laboratory sources. Phys. Rev. Appl.8, 064009. 10.1103/PhysRevApplied.8.064009
54
YoshitakeT.GiacomelliM. G.CahillL. C.SchmolzeD. B.VardehH.Faulkner-JonesB. E.et al (2016). Direct comparison between confocal and multiphoton microscopy for rapid histopathological evaluation of unfixed human breast tissue. J. Biomed. Opt.21, 126021. 10.1117/1.JBO.21.12.126021
55
ZanetteI.BechM.PfeifferF.WeitkampT. (2011). Interlaced phase stepping in phase-contrast x-ray tomography. Appl. Phys. Lett.98, 094101. 10.1063/1.3559849
56
ZanetteI.ZhouT.BurvallA.LundströmU.LarssonD.ZdoraM.et al (2014). Speckle-based x-ray phase contrast and dark-field imaging with a laboratory source. Phys. Rev. Lett.112, 253903. 10.1103/PhysRevLett.112.253903
57
ZhangX.WangJ.XingL. (2011). Metal artifact reduction in x-ray computed tomography (CT) by constrained optimization. Med. Phys.38, 701–711. 10.1118/1.3533711
Summary
Keywords
X-ray phase contrast, advanced X-ray imaging, intra-operative imaging, breast conserving surgery, wide local excisions
Citation
Olivo A and Leff DR (2025) X-ray phase contrast for intra-operative specimen imaging in breast conserving surgery and other areas. Front. Med. Eng. 3:1608247. doi: 10.3389/fmede.2025.1608247
Received
08 April 2025
Accepted
04 September 2025
Published
17 September 2025
Volume
3 - 2025
Edited by
Lorenzo Vannozzi, Institute of BioRobotics, Sant’Anna School of Advanced Studies, Italy
Reviewed by
Viorel Nastasa, Extreme Light Infrastructure Nuclear Physics, Romania
Andrew Leong, Los Alamos National Laboratory (DOE), United States
Updates

Check for updates
Copyright
© 2025 Olivo and Leff.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Alessandro Olivo, a.olivo@ucl.ac.uk
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.